Atlas Trials

Safety and Tolerability of NNC0141-0000-0100 in Subjects With Rheumatoid Arthritis

Clinical trial NCT01370902 · COMPLETED

Trial details

NCT number
NCT01370902
Sponsor
Innate Pharma
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
InflammationRheumatoid Arthritis
Start date
2011-05-01
Primary completion
2014-03-01
Enrollment
92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.